Randomized, 2-Way Crossover, Bioequivalence Study of Teva Pharmaceuticals USA and Merck Sharp & Dohme (USA) (Fosamax) Alendronate Sodium Tablets Administered as a 1 x 70 mg in Healthy Adult Males Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2010
At a glance
- Drugs Alendronic acid (Primary)
- Indications Osteoporosis
- Focus Pharmacokinetics
- 01 Jan 2010 Results were published in Arzneimittel-Forschung Drug Research.
- 07 Feb 2009 New trial record